A conserved tissue-specific homeodomain-less isoform of MEIS1 is downregulated in colorectal cancer

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Crist, Richard C ^a   Roth, Jacquelyn J ^a   Waldman, Scott A ^a   Buchberg, Arthur M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; COMPLEMENTARY DNA; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR MEIS1; TRANSCRIPTION FACTOR MEIS1D; UNCLASSIFIED DRUG; ISOPROTEIN; MYELOID ECOTROPIC VIRAL INTEGRATION SITE 1 PROTEIN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CYTOPLASM; ENZYME REGULATION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HOMEOBOX; HUMAN; HUMAN CELL; MEIS1 GENE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; ANIMAL; ANTIBODY SPECIFICITY; C57BL MOUSE; CECUM; CELL CULTURE; CELL STRAIN COS1; CELL STRAIN HCT116; CERCOPITHECUS; COLON; COLORECTAL TUMOR; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MURINAE;

ANIMALS; BLOTTING, WESTERN; CECUM; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COLON; COLORECTAL NEOPLASMS; COS CELLS; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 80051712965     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023665     Document Type: Article

References (41)

1. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981.
2. Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, et al. (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5: 736-742.
3. Terry P, Giovannucci E, Michels KB, Bergkvist L, Hansen H, et al. (2001) Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 93: 525-533.
4. van Engeland M, Weijenberg MP, Roemen GM, Brink M, de Bruine AP, et al. (2003) Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. Cancer Res 63: 3133-3137.
5. Bodmer WF, (2006) Cancer genetics: colorectal cancer as a model. J Hum Genet 51: 391-396.
6. Fearnhead NS, Wilding JL, Bodmer WF, (2002) Genetics of colorectal cancer: hereditary aspects and overview of colorectal tumorigenesis. Br Med Bull 64: 27-43.
7. Watson AJ, (2004) Apoptosis and colorectal cancer. Gut 53: 1701-1709.
8. Arber N, Hibshoosh H, Moss SF, Sutter T, Zhang Y, et al. (1996) Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110: 669-674.
9. Akiyama T, (2000) Wnt/beta-catenin signaling. Cytokine Growth Factor Rev 11: 273-282.
10. Jung C, Kim RS, Zhang H, Lee SJ, Sheng H, et al. (2005) HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. Br J Cancer 92: 2233-2239.
11. Cantile M, Franco R, Tschan A, Baumhoer D, Zlobec I, et al. (2009) HOX D13 expression across 79 tumor tissue types. Int J Cancer 125: 1532-1541.
12. Pearson JC, Lemons D, McGinnis W, (2005) Modulating Hox gene functions during animal body patterning. Nat Rev Genet 6: 893-904.
13. Hu M, Shivdasani RA, (2005) Overlapping gene expression in fetal mouse intestine development and human colorectal cancer. Cancer Res 65: 8715-8722.
14. Vider BZ, Zimber A, Hirsch D, Estlein D, Chastre E, et al. (1997) Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 232: 742-748.
15. Vider BZ, Zimber A, Chastre E, Gespach C, Halperin M, et al. (2000) Deregulated expression of homeobox-containing genes, HOXB6, B8, C8, C9, and Cdx-1, in human colon cancer cell lines. Biochem Biophys Res Commun 272: 513-518.
16. Cantile M, Franco R, Tschan A, Baumhoer D, Zlobec I, et al. (2009) HOX D13 expression across 79 tumor tissue types. Int J Cancer.
17. Silberg DG, Furth EE, Taylor JK, Schuck T, Chiou T, et al. (1997) CDX1 protein expression in normal, metaplastic, and neoplastic human alimentary tract epithelium. Gastroenterology 113: 478-486.
18. Ee HC, Erler T, Bhathal PS, Young GP, James RJ, (1995) Cdx-2 homeodomain protein expression in human and rat colorectal adenoma and carcinoma. Am J Pathol 147: 586-592.
19. Petrova TV, Nykanen A, Norrmen C, Ivanov KI, Andersson LC, et al. (2008) Transcription factor PROX1 induces colon cancer progression by promoting the transition from benign to highly dysplastic phenotype. Cancer Cell 13: 407-419.
20. Ryan AK, Rosenfeld MG, (1997) POU domain family values: flexibility, partnerships, and developmental codes. Genes Dev 11: 1207-1225.
21. Tucker SC, Wisdom R, (1999) Site-specific heterodimerization by paired class homeodomain proteins mediates selective transcriptional responses. J Biol Chem 274: 32325-32332.
22. Chariot A, Gielen J, Merville MP, Bours V, (1999) The homeodomain-containing proteins: an update on their interacting partners. Biochem Pharmacol 58: 1851-1857.
23. Hisa T, Spence SE, Rachel RA, Fujita M, Nakamura T, et al. (2004) Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. Embo J 23: 450-459.
24. Spieker N, van Sluis P, Beitsma M, Boon K, van Schaik BD, et al. (2001) The MEIS1 oncogene is highly expressed in neuroblastoma and amplified in cell line IMR32. Genomics 71: 214-221.
25. Sabates-Bellver J, Van der Flier LG, de Palo M, Cattaneo E, Maake C, et al. (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5: 1263-1275.
26. Geerts D, Revet I, Jorritsma G, Schilderink N, Versteeg R, (2005) MEIS homeobox genes in neuroblastoma. Cancer Lett 228: 43-50.
27. Xiong L, Catoire H, Dion P, Gaspar C, Lafreniere RG, et al. (2009) MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet 18: 1065-1074.
28. Todaro M, Francipane MG, Medema JP, Stassi G, (2010) Colon cancer stem cells: promise of targeted therapy. Gastroenterology 138: 2151-2162.
29. Geerts D, Schilderink N, Jorritsma G, Versteeg R, (2003) The role of the MEIS homeobox genes in neuroblastoma. Cancer Lett 197: 87-92.
30. Crijns AP, de Graeff P, Geerts D, Ten Hoor KA, Hollema H, et al. (2007) MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer 43: 2495-2505.
31. Huang H, Rastegar M, Bodner C, Goh SL, Rambaldi I, et al. (2005) MEIS C termini harbor transcriptional activation domains that respond to cell signaling. J Biol Chem 280: 10119-10127.
32. Stamm S, Riethoven JJ, Le Texier V, Gopalakrishnan C, Kumanduri V, et al. (2006) ASD: a bioinformatics resource on alternative splicing. Nucleic Acids Res 34: D46-55.
33. Yang Y, Hwang CK, D'Souza UM, Lee SH, Junn E, et al. (2000) Three-amino acid extension loop homeodomain proteins Meis2 and TGIF differentially regulate transcription. J Biol Chem 275: 20734-20741.
34. Magnani E, Hake S, (2008) KNOX lost the OX: the Arabidopsis KNATM gene defines a novel class of KNOX transcriptional regulators missing the homeodomain. Plant Cell 20: 875-887.
35. Noro B, Culi J, McKay DJ, Zhang W, Mann RS, (2006) Distinct functions of homeodomain-containing and homeodomain-less isoforms encoded by homothorax. Genes Dev 20: 1636-1650.
36. Knoepfler PS, Calvo KR, Chen H, Antonarakis SE, Kamps MP, (1997) Meis1 and pKnox1 bind DNA cooperatively with Pbx1 utilizing an interaction surface disrupted in oncoprotein E2a-Pbx1. Proc Natl Acad Sci U S A 94: 14553-14558.
37. Wu JY, Tang H, Havlioglu N, (2003) Alternative pre-mRNA splicing and regulation of programmed cell death. Prog Mol Subcell Biol 31: 153-185.
38. Lamba JK, Lamba V, Yasuda K, Lin YS, Assem M, et al. (2004) Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 311: 811-821.
39. Mei B, Zhao L, Chen L, Sul HS, (2002) Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing. Biochem J 364: 137-144.
40. Srebrow A, Kornblihtt AR, (2006) The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
41. Ward AJ, Cooper TA, (2009) The pathobiology of splicing. J Pathol 220: 152-163.